Additionally, exon skipping successfully restored dystrophin levels in patient-specific hiPSC-derived cardiomyocytes, providing clinically relevant evidence for the prevention of DMD-associated dilated cardiomyopathy (DCM) [243, 244]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.